Prospectus Supplement
(To Prospectus dated August 4, 2017)
4,000,000 SHARES
6.25% SERIES H CUMULATIVE REDEEMABLE
PERPETUAL PREFERRED SHARES
We are selling 4,000,000 shares of our 6.25% Series H Cumulative Redeemable Perpetual Preferred Shares of beneficial interest, $0.01 par value per share, or our Series H Preferred Shares, in this offering. This is the original issuance of our Series H Preferred Shares, which have a liquidation preference of $25.00 per share.
Holders of Series H Preferred Shares will be entitled to receive dividend payments only when, as and if declared by our board of trustees or a duly authorized committee of the board. Any such dividends will be payable from the date of original issue on a cumulative basis, quarterly in arrears on the last day of March, June, September and December of each year, commencing on December 31, 2018 to holders of record as of December 14, 2018. The dividend rate of 6.25% per annum will be applied to the liquidation preference from the date of issue. Payment of dividends on the Series H Preferred Shares is subject to certain legal and other restrictions as described elsewhere in this prospectus supplement.
We may, at our option, redeem the Series H Preferred Shares for cash in whole or in part, from time to time, at any time on or after September 19, 2023 as described under “Description of Series H Preferred Shares—Redemption—Redemption at Our Option,” at a redemption price of $25.00 per share, plus any accumulated and unpaid dividends. In addition, upon the occurrence of a Change of Control (as defined herein), we may, at our option, redeem the Series H Preferred Shares for cash, in whole or in part, within 120 days after the date on which such Change of Control occurred, by paying $25.00 per share, plus any accumulated and unpaid dividends to, but excluding, the date fixed for redemption. If we provided or provide notice of our election to redeem the Series H Preferred Shares, the holders of the Series H Preferred Shares will not be permitted to exercise the conversion right described below. The Series H Preferred Shares do not have any maturity date and will remain outstanding indefinitely, unless and until we decide to redeem them or they are converted in connection with a Change of Control by the holders of the Series H Preferred Shares. The Series H Preferred Shares will not have voting rights, except as set forth herein under “Description of Series H Preferred Shares—Voting Rights.”
Upon the occurrence of a Change of Control, each holder of Series H Preferred Shares will have the right to convert some or all of the Series H Preferred Shares held by such holder into Class A common shares of beneficial interest, $0.01 par value per share, or Class A common shares, as described herein under “Description of Series H Preferred Shares—Conversion Right upon a Change of Control,” unless, prior to the Change of Control Conversion Date (as defined herein), we have provided or provide notice of our election to redeem the Series H Preferred Shares as described herein under “Description of Series H Preferred Shares—Redemption.”
No current market exists for our Series H Preferred Shares. We intend to apply to list the Series H Preferred Shares on the New York Stock Exchange, or NYSE, under the symbol “AMHPRH.” If the listing application is approved, we expect trading of the Series H Preferred Shares to commence within 30 days after initial delivery of the shares.
Investing in our Series H Preferred Shares involves risks. See “Risk Factors” beginning on pageS-12 of this prospectus supplement and in the reports we file with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, incorporated by reference in this prospectus supplement and the accompanying prospectus, to read about factors you should consider before making an investment in the Series H Preferred Shares.
| | | | | | | | |
| | Per Share | | | Total | |
Public offering price | | $ | 25.0000 | | | $ | 100,000,000 | |
Underwriting discounts and commissions(1) | | $ | 0.7875 | | | $ | 3,150,000 | |
Proceeds, before expenses, to us | | $ | 24.2125 | | | $ | 96,850,000 | |
(1) | We refer you to “Underwriting” beginning onpage S-37 of this prospectus supplement for additional information regarding underwriter compensation. |
We have granted the underwriters an option to purchase up to an additional 600,000 Series H Preferred Shares from us at the public offering price, less the underwriting discount, within 30 days after the date of this prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the Series H Preferred Shares through The Depository Trust Company on or about September 19, 2018, which is the fifth business day following the pricing of this offering.
Joint Book-Running Managers
| | | | |
Wells Fargo Securities | | BofA Merrill Lynch | | Morgan Stanley |
Lead Managers
| | |
J.P. Morgan | | Raymond James |
Co-Managers
| | | | |
Jefferies | | Citigroup | | Goldman Sachs & Co. LLC |
| | |
US Bancorp | | Ramirez & Co., Inc. |
Prospectus Supplement dated September 12, 2018